Pathobiology of liver fibrosis: a translational success story - sprookjes - yvandenbroek - TriplyDB

Pathobiology of liver fibrosis: a translational success story

Pathobiology of liver fibrosis: a translational success story

http://www.wikidata.org/entity/Q34462733

about

Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts Connexins and pannexins in liver damage Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase Liver pathology of hepatitis C, beyond grading and staging of the disease Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts Molecular prognostic prediction in liver cirrhosis Reversibility of liver fibrosis Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Evaluation of liver fibrosis: "Something old, something new…"Promising therapies for treatment of nonalcoholic steatohepatitis.Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.The spleen in liver cirrhosis: revisiting an old enemy with novel targets.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.20S-Protopanaxadiol, an aglycosylated ginsenoside metabolite, induces hepatic stellate cell apoptosis through liver kinase B1-AMP-activated protein kinase activation.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin Hepatitis C virus-induced hepatocellular carcinoma Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma.HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.Changes of the Cytoplasmic Proteome in Response to Alcoholic Hepatotoxicity in Rats.Liver fibrosis: Review of current imaging and MRI quantification techniques.Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.Surgical Management of Chronic Pancreatitis.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Transcriptional control of cardiac fibroblast plasticity.The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.

P2860

Q26745566-128217AC-53BE-4426-82A1-C4EEBA8B982E Q26750050-E51302EB-241D-4063-829E-F244351A2DD1 Q26753022-D6DB608D-9EFF-4A52-90C3-AC50077A9F48 Q26765898-72D65966-7D63-47B6-806D-E1C4D5A471FC Q26766533-197A3CAD-2781-487D-8636-19B192E85B93 Q26771779-500F03CA-FF47-4664-9B28-3EF229921162 Q26773294-C7D59FF8-7A88-439F-8711-ED64CD006087 Q26776162-EDAB8581-F56E-4717-BCA3-3347D6EAA2D6 Q26784251-8112C318-CB1D-41E8-92BD-830CA275C1F6 Q26822053-BACE673E-DBDF-44ED-9B1D-273561AE60BB Q27336127-F3D6634F-CF35-4A13-8918-0AA066571A02 Q28066233-71D7EE91-4BDC-4039-A88C-0C3FDD514760 Q28068532-6AEC62D1-E78B-49C9-89A5-19DD58898AC3 Q30248578-29238E4A-8000-4301-9C2E-1D015C030796 Q30250322-B0960E67-6A32-4184-B734-840551FE41BF Q30355782-E71D1CF5-BA5D-4BAB-BF77-34AB8B280E96 Q31171499-8842A903-0E8A-407E-A8AA-D424AD77E8C9 Q33574413-75CE7CDE-4856-4810-80C4-E2A97EEA812B Q33579420-F200C7A6-1B8E-44C7-8C2B-1BCA3E638040 Q33605760-8C2F709B-B860-4189-BEB1-2FDCF3CB44D3 Q33826344-51FC64A8-D712-47AD-BAC0-291EDB3A662F Q33850019-9C69E9D3-4D8C-44F7-B7CD-DD1648970D4D Q33877800-9080E987-848C-4D3A-965C-7E80C467B71E Q35824057-87D43A82-2D28-42D8-8C15-F4FDE556738C Q35903372-7E33F961-EF88-43AA-9D55-40C8CB5ED6F0 Q36022359-149AAF21-9860-48C7-8B4C-A0192455876C Q36065064-2EF76EB3-2A92-4DA4-A009-13120CAB920D Q36088607-9DB3AD2B-FA62-4837-B4C0-4F7F5CC1BE05 Q36226373-CCA5A9F5-DE8E-4FF8-8939-F2342C320200 Q36259454-1B172B84-C6D0-4E1E-94C8-B96CDBA1EAB3 Q36279532-08D3982F-B8AB-4A9A-B130-1311F4439C64 Q36400091-7D1B8451-52E6-46E4-A8D7-AA4328A36546 Q36588292-5B3EEAF2-5E2A-4975-9F82-096C1CA6757D Q36609712-6BBCBE6B-3BA1-4454-A306-3AD36A0E3700 Q36783013-23FF9B87-F935-4508-8B78-D1994FC518C7 Q36947366-C6A6321D-599C-429D-8EA3-4F929BEB85BF Q37112309-1839075E-126B-4FB8-8384-A1ADD6648A4A Q37164508-F007EC5E-BCEF-4558-998C-9B7EFA415647 Q37431827-E7AB7154-E2A2-4337-924A-6CE667902BB6 Q37544826-45507BA4-E0F6-46D0-88D9-30955F7F3AB7

P2860

Pathobiology of liver fibrosis: a translational success story

http://www.wikidata.org/entity/Q34462733

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pathobiology of liver fibrosis: a translational success story

@ast

Pathobiology of liver fibrosis: a translational success story

@en

Pathobiology of liver fibrosis: a translational success story

@nl

type

label

Pathobiology of liver fibrosis: a translational success story

@ast

Pathobiology of liver fibrosis: a translational success story

@en

Pathobiology of liver fibrosis: a translational success story

@nl

prefLabel

Pathobiology of liver fibrosis: a translational success story

@ast

Pathobiology of liver fibrosis: a translational success story

@en

Pathobiology of liver fibrosis: a translational success story

@nl

P1433

Q34462733-BBA5C598-EF23-4D16-9EE3-4EADEE559FB8

P1476

Q34462733-24EF3BD5-24DC-4F0C-AB47-2B365669E84F

P2093

Q34462733-00B55CF9-CEAF-4266-8B15-CE8905614976

Q34462733-AD1D20F1-C6F1-4007-A571-2BB317E6B18A

Q34462733-D738AF70-8CDB-4356-B340-865EE94C7F37

P2860

Q34462733-0057A5CA-CEA5-412B-8F68-8D73E27C696B

Q34462733-0235B40E-8E3C-4117-AAC5-F05BB209FD9F

Q34462733-03197D3F-85D3-47AB-ADF9-8A80A3950077

Q34462733-033A7F9D-EEC0-41BF-AA44-CABE77024EBF

Q34462733-036E01CF-856E-41CC-B932-25D11BBC8657

Q34462733-03BAFC3A-C4B6-47D1-98C8-84EF9F509CC4

Q34462733-066B810D-9797-48D7-B56A-AB0DD5ED6025

Q34462733-080E0F6A-29B5-481C-938D-F7602D2354FB

Q34462733-08402362-8415-4DFE-8A88-4A0F8C977F3A

Q34462733-0A92BC50-C245-4E35-92CF-F102F24FDF29

P304

Q34462733-A9F52C48-F82D-4A51-90C3-3A7F5718362C

P31

Q34462733-ECAE4A6B-D129-4111-8AAD-781999A380E1

P356

Q34462733-3F4A52DB-1B3F-4900-8969-C80035B996AF

P407

Q34462733-CCDA0BBE-4799-4A14-8040-E638DC6D314A

P433

Q34462733-5B37E87E-8C10-4746-9B4B-D1F93A8AD567

P478

Q34462733-04DAD6A2-A8E2-4954-8EC2-2E8362991ED9

P577

Q34462733-E4E7C182-F1EC-4C47-923F-992038F85888

P698

Q34462733-181824F8-E3C7-43F1-A982-62ED7EA074F6

P932

Q34462733-E966B0F2-EFF1-4E67-9B84-BCFBA2115A00

P356

GUTJNL-2014-306842

P1433

P1476

Pathobiology of liver fibrosis: a translational success story

@en

P2093

Michael C Wallace

http://www.w3.org/2001/XMLSchema#string

Scott L Friedman

http://www.w3.org/2001/XMLSchema#string

Youngmin A Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Senescence of activated stellate cells limits liver fibrosis

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Decoding cell death signals in liver inflammation

Epigenetics in liver disease

Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

Systematic review: the effects of autologous stem cell therapy for patients with liver disease

Liver sinusoidal endothelial cells and liver regeneration

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

P304

830-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2014-306842

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25681399

http://www.w3.org/2001/XMLSchema#string

P932

4477794

http://www.w3.org/2001/XMLSchema#string